98%
921
2 minutes
20
In survival analysis, researchers commonly focus on variable selection issues in real-world data, particularly when complex network structures exist among covariates. Additionally, due to factors such as data collection costs and delayed entry, real-world data often exhibit censoring and truncation phenomena.This paper addresses left-truncated current status data by employing a copula-based approach to model the relationship between censoring time and failure time. Based on this, we investigate the problem of variable selection in the context of complex network structures among covariates. To this end, we integrate Markov Random Field (MRF) with the Proportional Hazards (PH) model, and extend the latter to more flexibly characterize the correlation structure among covariates. For solving the constructed model, we propose a penalized optimization method and utilize spline functions to estimate the baseline hazard function. Through numerical simulation experiments and case studies of clinical trial data, we comprehensively evaluate the effectiveness and performance of the proposed model and its parameter inference strategy. This evaluation not only demonstrates the robustness of the proposed model in handling complex disease data but also further verifies the high precision and reliability of the parameter estimation method.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10985-025-09655-0 | DOI Listing |
JAMA Neurol
September 2025
Department of Radiology, University of Washington, Seattle.
Importance: Recent longitudinal studies in patients with unruptured intracranial aneurysms (UIAs) suggested that aneurysm wall enhancement (AWE) on magnetic resonance imaging (MRI) predicts growth and rupture. However, because these studies were limited by small sample size and short follow-up duration, it remains unclear whether this radiological biomarker has predictive value for UIA instability.
Objective: To determine the 4-year risk of instability of UIAs with AWE and investigate whether AWE is an independent predictor of UIA instability.
JAMA Netw Open
September 2025
Department of Epidemiology, University of Texas Health Science Center at Houston School of Public Health, Houston.
Importance: Trisomy 13 (T13) and trisomy 18 (T18) are chromosomal abnormalities with high mortality rates in the first year of life. Understanding differences in long-term survival between children with full vs mosaic or partial trisomy is crucial for prognosis and health care planning.
Objective: To examine the differences in 10-year survival between children with full T13 and T18 vs those with mosaic or partial trisomy.
Osteoporos Int
September 2025
University of Alabama at Birmingham, Birmingham, AL, USA.
Unlabelled: Higher area socioeconomic level was associated with a decreased risk of romosozumab discontinuation during COVID-19 lockdown among U.S. Medicare beneficiaries.
View Article and Find Full Text PDFJ Dev Behav Pediatr
September 2025
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Objective: We sought to measure whether receipt of an enhanced 18-month well-baby visit with use of a developmental screening tool versus a routine 18-month well-baby visit (which typically involves developmental surveillance without screening) is associated with time to identification of developmental delays.
Method: We conducted a cohort study of children (17-22 months) in Ontario who received an 18-month well-baby visit (March 2020‒March 2022), followed to September 2022 using linked health administrative datasets. Visits were categorized as enhanced (n = 83,554) or routine (n = 15,723).
J Thorac Oncol
July 2025
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Introduction: TNM staging systems create prognostic categories by anatomic extent of disease. Whether therapeutically important molecular alterations in NSCLC augment the prognostic information of TNM staging is unclear. To study this, we analyzed molecular data from the ninth edition of the lung cancer staging system.
View Article and Find Full Text PDF